Ariad Pharmaceuticals, Inc. Announces 2008 Key Corporate Objectives and Plans for Development of Its Lead Oncology Product Candidates

CAMBRIDGE, Mass.--(BUSINESS WIRE)--ARIAD Pharmaceuticals, Inc. (Nasdaq: ARIA) today announced 2008 key corporate objectives and financial guidance, details of which will be presented at the 26th Annual JPMorgan Healthcare Conference on January 9, 2008 in San Francisco, California.

MORE ON THIS TOPIC